MBX Biosciences, Inc. - MBX
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Nov 05, 2026 | SCHEDULE 13G/A | FMR LLC | 15.0% | 7,224,009 | View |
| Nov 05, 2026 | SCHEDULE 13G/A | Abigail P. Johnson | 15.0% | 7,224,009 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Deep Track Capital, LP | 3.64% | 1,732,569 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Deep Track Biotechnology Master Fund, Ltd. | 3.64% | 1,732,569 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | David Kroin | 3.64% | 1,732,569 | View |
| Aug 10, 2026 | SCHEDULE 13D/A | — | — | — | View |
| Aug 10, 2026 | SCHEDULE 13D/A | — | 1.0% | — | View |
| Jul 29, 2026 | SCHEDULE 13G | BlackRock, Inc. | 5.5% | 2,628,181 | View |
| Jul 08, 2026 | SCHEDULE 13G/A | Wellington Management Group LLP | 10.5% | 4,977,523 | View |
| Jul 08, 2026 | SCHEDULE 13G/A | Wellington Group Holdings LLP | 10.5% | 4,977,523 | View |
| Jul 08, 2026 | SCHEDULE 13G/A | Wellington Investment Advisors Holdings LLP | 10.5% | 4,977,523 | View |
| Jul 08, 2026 | SCHEDULE 13G/A | Wellington Management Company LLP | 9.8% | 4,977,523 | View |
| Jul 08, 2026 | SCHEDULE 13G/A | FMR LLC | 11.2% | 5,322,885 | View |
| Jul 08, 2026 | SCHEDULE 13G/A | Abigail P. Johnson | 11.2% | 5,322,885 | View |
| Jun 24, 2026 | SCHEDULE 13G | Paradigm BioCapital Advisors LP | 5.2% | 2,493,015 | View |
| Jun 24, 2026 | SCHEDULE 13G | Paradigm BioCapital Advisors GP LLC | 5.2% | 2,493,015 | View |
| Jun 24, 2026 | SCHEDULE 13G | Senai Asefaw, M.D. | 5.2% | 2,493,015 | View |
| Jun 24, 2026 | SCHEDULE 13G | Paradigm BioCapital International Fund Ltd. | 4.6% | 2,187,207 | View |
| May 06, 2026 | SCHEDULE 13G | FMR LLC | 6.2% | 2,936,684 | View |
| May 06, 2026 | SCHEDULE 13G | Abigail P. Johnson | 6.2% | 2,936,684 | View |
| Apr 27, 2026 | SCHEDULE 13G/A | BlackRock, Inc. | 4.8% | 2,287,497 | View |
| Feb 10, 2026 | SCHEDULE 13G/A | Wellington Management Group LLP | 7.5% | 3,349,961 | View |
| Feb 10, 2026 | SCHEDULE 13G/A | Wellington Group Holdings LLP | 7.5% | 3,349,961 | View |
| Feb 10, 2026 | SCHEDULE 13G/A | Wellington Investment Advisors Holdings LLP | 7.5% | 3,349,961 | View |
| Feb 10, 2026 | SCHEDULE 13G/A | Wellington Management Company LLP | 7.3% | 3,349,961 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | P. Kent Hawryluk | 4.3% | 1,995,759 | View |
| Nov 12, 2025 | SCHEDULE 13G/A | Wellington Biomedical Innovation Master Investors (Cayman) II, L.P. | 4.5% | 2,017,394 | View |
| Oct 06, 2025 | SCHEDULE 13G/A | Wellington Management Group LLP | 10.8% | 4,823,336 | View |
| Oct 06, 2025 | SCHEDULE 13G/A | Wellington Group Holdings LLP | 10.8% | 4,823,336 | View |
| Oct 06, 2025 | SCHEDULE 13G/A | Wellington Investment Advisors Holdings LLP | 10.8% | 4,823,336 | View |
| Oct 06, 2025 | SCHEDULE 13G/A | Wellington Management Company LLP | 10.6% | 4,823,336 | View |
| Aug 14, 2025 | SCHEDULE 13G/A | Deep Track Capital, LP | 6.55% | 2,188,592 | View |
| Aug 14, 2025 | SCHEDULE 13G/A | Deep Track Biotechnology Master Fund, Ltd. | 6.55% | 2,188,592 | View |
| Aug 14, 2025 | SCHEDULE 13G/A | David Kroin | 6.55% | 2,188,592 | View |
| Aug 12, 2025 | SCHEDULE 13G/A | Wellington Management Group LLP | 6.8% | 2,266,628 | View |
| Aug 12, 2025 | SCHEDULE 13G/A | Wellington Group Holdings LLP | 6.8% | 2,266,628 | View |
| Aug 12, 2025 | SCHEDULE 13G/A | Wellington Investment Advisors Holdings LLP | 6.8% | 2,266,628 | View |
| Aug 12, 2025 | SCHEDULE 13G/A | Wellington Management Company LLP | 6.8% | 2,266,628 | View |
| May 12, 2025 | SCHEDULE 13G/A | Wellington Management Group LLP | 7.9% | 2,638,521 | View |
| May 12, 2025 | SCHEDULE 13G/A | Wellington Group Holdings LLP | 7.9% | 2,638,521 | View |
| May 12, 2025 | SCHEDULE 13G/A | Wellington Investment Advisors Holdings LLP | 7.9% | 2,638,521 | View |
| May 12, 2025 | SCHEDULE 13G/A | Wellington Management Company LLP | 7.8% | 2,638,521 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.